Supporting the Growth and Advancements in Dermatology

Syneron's ePrime, CO2RE and eMatrix Exemplify Novel Craftsmanship for Today's Practitioners Attending the American Academy of Dermatology's Summer Academy Meeting in New York, NY

 

"Educational extensions like the Summer Academy Meeting hosted by the American Academy of Dermatology motivates us throughout the year to pioneer innovative and current solutions for our core physician partners," said Louis P. Scafuri, Chief Executive Officer of Syneron and Candela Corporation. "Each of our products are conceived and developed with today's practitioners in mind. We remain committed to undertake the appropriate investment in scientific work necessary to demonstrate that our products and technologies deliver exceptional results. It is our goal to earn the trust of the professionals to whom we sell."

 

Read more at MarketWire,  MarketWatch , IStockAnalyst or Syneron Official PR

 

 

 

 

 

See more in:

Syneron® manufactures and sells ablative and non-ablative medical aesthetic devices that use a wide variety of energies including Syneron®'s signature elos™ technology - the only combined energy platform (radio frequency and light energies) that effectively treats dermatological conditions including wrinkles, age spots, pigmentation, acne, rosacea, hair removal, leg veins, spider veins, and much more. The VelaShape™ and Lipolite™ devices provide safe & effective treatments for cellulite and circumferential reduction, and the newly introduced Matrix RF™ is the first RF-only, non-laser, non-light device that's FDA cleared for fractional resurfacing.  Syneron® products are sold to dermatologists, plastic surgeons, family practitioners and other physicians, aestheticians, and medical spa professionals around the world.